Stock comparison
Alphatec Holdings
Haemonetics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ATEC
Alphatec Holdings
Market cap
$1.27B
Sector
Healthcare
HAE
Haemonetics
Market cap
$2.98B
Sector
Healthcare
Overall winner
Haemonetics HAE
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ATEC | HAE | Winner |
|---|---|---|---|
| Warren Buffett | 26F | 70B | HAE |
| Benjamin Graham | 65D | 85A | HAE |
| Philip Fisher | 50C | 60C | HAE |
| Peter Lynch | 71C | 54C | ATEC |
| Joel Greenblatt | 0F | 31F | HAE |
| Charlie Munger | 37D | 54D | HAE |
| Terry Smith | 33F | 55D | HAE |
Side-by-side metrics
| Metric | ATEC | HAE |
|---|---|---|
| Market cap | $1.27B | $2.98B |
| P/E (TTM) | - | 24.8x |
| EV/EBIT | - | 14.1x |
| ROIC (TTM) | -8.94% | 8.37% |
| Gross margin | 65.32% | 55.74% |
| Net margin | -15.93% | 7.29% |
| Revenue CAGR 5y | 33.14% | 7.65% |
| EPS CAGR 5y | - | 24.62% |
| Debt / Equity | 33.0x | 1.5x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ATEC leads on
- EV/EBIT-vs 14.1x+170%
- P/E (TTM)-vs 24.8x+139%
- Revenue CAGR 5y33.14%vs 7.65%+77%
- Gross margin65.32%vs 55.74%+15%
HAE leads on
- ROIC (TTM)8.37%vs -8.94%+194%
- Net margin7.29%vs -15.93%+146%
- Debt / Equity1.5xvs 33.0x+95%
- Market cap$2.98Bvs $1.27B+57%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.